Additional impact of morning haemostatic risk factors and morning blood pressure surge on stroke risk in older Japanese hypertensive patients

European Heart Journal

Volumn 32, Issue 5, 2011, Pages 574-580

  Kario, Kazuomi ^a   Yano, Yuichirou ^a   Matsuo, Takefumi ^b   Hoshide, Satoshi ^a   Eguchi, Kazuo ^a   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b HYOGO PREFECTURAL AWAJI HOSPITAL   (Japan)

Author keywords

Fibrinogen; Morning blood pressure surge; Plasminogen activator inhibitor 1; Prothrombin fragment 1+2; Stroke

Indexed keywords

FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN COMPLEX;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; STROKE; SYSTOLIC BLOOD PRESSURE; TIME;

AGED; AGED, 80 AND OVER; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; FIBRINOGEN; HEMOSTASIS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSPECTIVE STUDIES; PROTHROMBIN; STROKE; TIME FACTORS;

EID: 79952352766     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq444     Document Type: Article

References (26)

1. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989;79:733-743. (Pubitemid 19100532)
2. White WB. Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate. Blood Press Monit 2001;6:63-72. (Pubitemid 32587662)
3. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003;107:1401-1406. (Pubitemid 36350739)
4. Gosse P, Lasserre R, Minifié C, Lemetayer P, Clementy J. Blood pressure surge on rising. J Hypertens 2004;22:1113-1138.
5. Metoki H, Ohkubo T, Kikuya M, Asayama K, Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study. Hypertension 2006;47:149-154. (Pubitemid 43189756)
6. Folsom AR, Rosamond WD, Shahar E, Cooper LS, Aleksic N, Nieto FJ, Rasmussen ML, Wu KK. Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 1999;100:736-742. (Pubitemid 29383644)
7. Côté R, Wolfson C, Solymoss S, Mackey A, Leclerc JR, Simard D, Rouah F, Bourque F, Léger B. Hemostatic markers in patients at risk of cerebral ischemia. Stroke 2000;31:1856-1862. (Pubitemid 30620463)
8. Smith A, Patterson C, Yarnell J, Rumley A, Ben-Shlomo Y, Lowe G. Which hemo-static markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study. Circulation 2005;112: 3080-3087. (Pubitemid 43113439)
9. Sato S, Iso H, Noda H, Kitamura A, Imano H, Kiyama M, Ohira T, Okada T, Yao M, Tanigawa T, Yamagishi K, Nakamura M, Naito Y, Shimamoto T. Plasma fibrinogen concentrations and risk of stroke and its subtypes among Japanese men and women. Stroke 2006;37:2488-2492. (Pubitemid 44454666)
10. Angleton P, Chandler WL, Schmer G. Diurnal variation of tissue-type plasmino-gen activator and its rapid inhibitor (PAI-1). Circulation 1989;79:101-106. (Pubitemid 19043680)
11. Kapiotis S, Jilma B, Quehenberger P, Ruzicka K, Handler S, Speiser W. Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex. Circulation 1997;96:19-21. (Pubitemid 27298396)
12. Huber K, Rosc D, Resch I, Schuster E, Glogar DH, Kaindl F, Binder BR. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myo-cardial infarction. Thromb Haemost 1988;60:372-376. (Pubitemid 19023725)
13. Sayer JW, Gutteridge C, Syndercombe-Court D, Wilkinson P, Timmis AD. Circa-dian activity of the endogenous fibrinolytic system in stable coronary artery disease: effects of beta-adrenoreceptor blockers and angiotensin- converting enzyme inhibitors. J Am Coll Cardiol 1998;32:1962-1928.
14. Kario K, Pickering TG, Hoshide S, Eguchi K, Ishikawa J, Morinari M, Hoshide Y, Shimada K. Morning blood pressure surge and hypertensive cerebrovascular disease: role of the alpha adrenergic sympathetic nervous system. Am J Hypertens 2004;17:668-675. (Pubitemid 39091547)
15. Alessi MC, Juhan-Vague I. PAI-1 and the metabolic syndrome: links, causes, and consequences. Arterioscler Thromb Vasc Biol 2006;26:2200-2207. (Pubitemid 44465712)
16. Ishikawa J, Tamura Y, Hoshide S, Eguchi K, Ishikawa S, Shimada K, Kario K. Low-grade inflammation is a risk factor for clinical stroke events in addition to silent cerebral infarcts in Japanese older hypertensives: the Jichi Medical School ABPM Study, wave 1. Stroke 2007;38:911-917. (Pubitemid 46568452)
17. Kario K, Matsuo T, Kobayashi H, Hoshide S, Shimada K. Hyperinsulinemia and hemostatic abnormalities are associated with silent lacunar cerebral infarcts in elderly hypertensive subjects. J Am Coll Cardiol 2001;37:871-877. (Pubitemid 32202457)
18. Ueshima H, Sekikawa A, Miura K, Turin TC, Takashima N, Kita Y, Watanabe M, Kadota A, Okuda N, Kadowaki T, Nakamura Y, Okamura T. Cardiovascular disease and risk factors in Asia: a selected review. Circulation 2008;118: 2702-2709.
19. Van Goor ML, Gómez Garća E, Leebeek F, Brouwers GJ, Koudstaal P, Dippel D. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study. Thromb Haemost 2005;93: 92-96.
20. Tohgi H, Utsugisawa K, Yoshimura M, Nagane Y, Ukitsu M. Local variation in expression of pro- and antithrombotic factors in vascular endothelium of human autopsy brain. Acta Neuropathol 1999;98:111-118. (Pubitemid 29355542)
21. Hafer-Macko CE, Ivey FM, Sorkin JD, Macko RF. Microvascular tissue plasminogen activator is reduced in diabetic neuropathy. Neurology 2007;69:268-274. (Pubitemid 47205689)
22. Lip GY. Target organ damage and the prothrombotic state in hypertension. Hypertension 2000;36:975-977.
23. Aono Y, Ohkubo T, Kikuya M, Hara A, Kondo T, Obara T, Metoki H, Inoue R, Asayama K, Shintani Y, Hashimoto J, Totsune K, Hoshi H, Satoh H, Izumi S, Imai Y. Plasma fibrinogen, ambulatory blood pressure, and silent cerebrovascular lesions: the Ohasama study. Arterioscler Thromb Vasc Biol 2007;27:963-968. (Pubitemid 46606732)
24. Tanizaki Y, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Shinohara N, Arima H, Tanaka K, Ibayashi S, Fujishima M. Incidence and risk factors for subtypes of cerebral infarction in a general population: the Hisayama study. Stroke 2000;31: 2616-2622.
25. Rothwell PM, Howard SC, Power DA, Gutnikov SA, Algra A, Van Gijn J, Clark TG, Murphy MF, Warlow CP. Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke. Stroke 2004;35:2300-2305. (Pubitemid 39311253)
26. Clarke R, Shipley M, Lewington S, Youngman L, Collins R, Marmot M, Peto R. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 1999;150:341-353. (Pubitemid 29383482)